Coronavirus vaccine developer CureVac shares surge in Nasdaq debut - Reuters
9:28am PDT - August 14th, 2020 stock-market - ReutersShares of German biotechnology firm CureVac BV soared 175% in their Nasdaq debut on Friday, marking the first stock market listing of a company developing a potential vaccine to combat the coronavirus.